Study of YK012 in Primary Membranous Nephropathy

NCT06982729 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
72
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Excyte Biopharma Ltd